HPV in the United States and Developing Nations: A Problem of Public Health or Politics? The Global AIDS bill, signed into law on May 27, 2003 by President Bush [for full text: Library of Congress, search bill number, H.R. 1298.] requires an analysis of the prevalence of human … [Read more...] about HPV — A Problem of Public Health or Politics?
HPV Infection
Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market
Merck’s Lybrand Plays It Cool In Midst Of Hot Controversy
News Analysis From BrandWeek Red flags raised by parents, politicians over Gardasil STD vaccine. To hear Beverly Lybrand tell it, you would not know she's a brand manager in the midst of a storm—over sex, teen girls, sexually transmitted diseases and cancer—that is currently … [Read more...] about Merck’s Lybrand Plays It Cool In Midst Of Hot Controversy
New HPV Numbers Don’t Look Good For Gardasil
JAMA Jammin' Merck's HPV Numbers Merck's Stat-Spinners looking for a way around two key findings from a new study in JAMA: one in four women have HPV, which is higher than previously thought. the incidence of the two strains responsible for most cervical cancer is actually … [Read more...] about New HPV Numbers Don’t Look Good For Gardasil
Oral Contraceptives, HPV and Risk of Cervical Cancer
Global Research Sources—Asking Questions Ignored by FDA An analysis of case-control studies has found that use of oral contraceptives for ≥ 5 years in women with human papillomavirus (HPV) infection is associated with an increased risk of cervical cancer. This confirms … [Read more...] about Oral Contraceptives, HPV and Risk of Cervical Cancer